| publication_id |
reference_id |
| 946 |
Waki K, Terasaki PI, Kadowaki T. Long Term Pancreas Allograft Survival in Simultaneous Pancreas Kidney Transplantation by Era: UNOS Registry Analysis. Diabetes Care. 2010 |
| 945 |
Goh A, Scalamogna M, De Feo T, Poli F, Terasaki PI. Human leukocyte antigen crossmatch testing is important for liver retransplantation. Liver Transpl 2010;16(3):308-313. |
| 944 |
El-Awar N, Terasaki PI, Nguyen A, Lias M, Conger N. New HLA class I epitopes defined by murine monoclonal antibodies. Hum Immunol 2010;71(5):456-461. |
| 943 |
Everly MJ, Rebellato LM, Ozawa M, Briley KP, Catrou PG, Haisch CE et al. Beyond histology: lowering human leukocyte antigen antibody to improve renal allograft survival in acute rejection. Transplantation 2010;89(8):962-967 |
| 942 |
Ravindranath MH, Taniguchi M, Chen CW, Ozawa M, Kaneku H, El-Awar N et al. HLA-E monoclonal antibodies recognize shared peptide sequences on classical HLA class Ia: relevance to human natural HLA antibodies. Mol Immunol 2010;47(5):1121-1131 |
| 941 |
Terasaki PI. The review by Kwun and Knechtle-"can it B?"-asks whether B cells are responsible for chronic rejection of transplants. Transplantation 2009;88(8):978-979. |
| 940 |
Lee PC, Zhu L, Terasaki PI, Everly MJ. HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss. Transplantation 2009;88(4):568-574 |
| 939 |
Cai J, Terasaki PI, Anderson N, Lachmann N, Schonemann C. Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure. Transplantation 2009;88(2):226-230 |
| 938 |
El-Awar N, Terasaki PI, Nguyen A, Sasaki N, Morales-Buenrostro LE, Saji H et al. Epitopes of human leukocyte antigen class I antibodies found in sera of normal healthy males and cord blood. Hum Immunol 2009;70(10):844-853 |
| 937 |
Trivedi HL, Terasaki PI, Feroz A, Everly MJ, Vanikar AV, Shankar V et al. Abrogation of anti-HLA antibodies via proteasome inhibition. Transplantation 2009;87(10):1555-1561 |
| 936 |
Lachmann N, Terasaki PI, Budde K, Liefeldt L, Kahl A, Reinke P et al. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts. Transplantation 2009;87(10):1505-1513 |
| 935 |
Everly MJ, Terasaki PI. Monitoring and treating posttransplant human leukocyte antigen antibodies. Hum Immunol 2009;70(8):655-659. |
| 934 |
Delgado JC, Fuller A, Ozawa M, Smith L, Terasaki PI, Shihab FS et al. No occurrence of de novo HLA antibodies in patients with early corticosteroid withdrawal in a 5-year prospective randomized study. Transplantation 2009;87(4):546-548. |
| 933 |
Morales-Buenrostro LE, Terasaki PI, Marino-Vazquez LA, Lee J, El-Awar N, Alberu J. “Natural” HLA antibodies found in nonalloimmunized healthy males. Transplantation 2008; 86:1111-15 |
| 932 |
Cai J, Terasaki PI. Post-transplantation antibody monitoring and HLA antibody epitope identification. Curr Opin Immunol, 2008; 20(5) 602-6 |
| 931 |
Sasaki N, Idica A, Terasaki PI. Mimetic HLA epitopes: shown by monoclonal antibodies and extra antibodies produced on transplantation. Transplantation 2008; 86:912-18 |
| 930 |
Terasaki PI, Cai J. HLA antibodies and chronic rejection: From association to causation. Transplantation 2008;86; 377-383. |
| 929 |
Chun-Tsan Deng, Nadim El-Awar, Miyuki Ozawa, Junchao Cai, Nils Lachmann, Paul I. Terasaki. HLA Class II DQ alpha and beta epitopes identified from sera of kidney allograft recipients Transplantation 2008;86; 452-459. |
| 928 |
Luis E. Morales-Buenrostro, Rene Castro, Paul I. Terasaki. A Single Human Leukocyte Antigen-Antibody Test After Heart or Lung Transplantation Is Predictive of Survival Trnasplantation 2008; 85:478-481 |
| 927 |
Terasaki PI. A brief history of HLA. Immunol Res (2007) 38:139-148. |
| |
Publications